Prevalence of End Stage Kidney Disease and distribution of treatment modalities

Nephrol Ther. 2023 Aug 28;18(S2):25-30. doi: 10.1016/S1769-7255(22)00563-6.ABSTRACTOn the occasion of the 20th anniversary of the REIN (French Renal Epidemiology and Information Network), a summary work on the contributions of the national French ESKD register was carried out. On the issue of ESKD prevalence, the following key messages were retained. While chronic kidney disease affects all age groups, there always are more patients to treat in the older age groups, with a median age of 71.1 years (IIQ 60.3-80.0) under dialysis and 58.7 years (IIQ 47.4-68.3) under renal transplant. Despite an increase in transplant activity and improved survival of grafts, the gap between the number of dialysis patients and transplant patients at the end of each year is only moderately reduced. There has been a moderate decrease in the proportion of in-centre haemodialysis that is explained by a significant increase in medicalised dialysis units (out-centre haemodialysis) and a decrease in self-care haemodialysis. Finally, a stable home-based care has been observed despite the ministerial incentives and the recommendations of the French-speaking scientific society (SFNDT-white paper).PMID:37638504 | DOI:10.1016/S1769-7255(22)00563-6
Source: Nephrologie and Therapeutique - Category: Urology & Nephrology Authors: Source Type: research